BioNTech SE (BNTX) Non Operating Income (2020 - 2025)
BioNTech SE's (BNTX) quarterly Non Operating Income came in at $111.4 million in Q2 2025, down 35.52% year-on-year from $172.7 million in Q2 2024, and up 19.38% quarter-over-quarter from $93.3 million in Q1 2025.
BioNTech SE (BNTX) Non Operating Income (2020 - 2025) Analysis & Trends
BioNTech SE has disclosed Non Operating Income across 6 years of filings, most recently posting $111.4 million for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 111.38 Mn |
| Mar 31, 2025 | 93.30 Mn |
| Jun 30, 2024 | 172.73 Mn |
| Mar 31, 2024 | 190.55 Mn |
| Jun 30, 2023 | 164.54 Mn |
| Mar 31, 2023 | 57.21 Mn |
| Sep 30, 2022 | 113.63 Mn |
| Sep 30, 2021 | 66.16 Mn |
| Sep 30, 2020 | 24.65 Mn |